Intestinal ultrasound score predicts therapeutic outcomes of infliximab in pediatric patients with Crohn’s disease

References

• Turner D, Ricciuto A, Lewis A, et al. STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology. 2021;160(5):1570–1583. doi: 10.1053/j.gastro.2020.12.031.
   PubMed Web of Science ®Google Scholar
• Daperno M, D’Haens G, Van Assche G, et al. Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: the SES-CD. Gastrointest Endosc. 2004;60(4):505–512. doi: 10.1016/s0016-5107(04)01878-4.
   PubMed Web of Science ®Google Scholar
• Mary JY, Modigliani R. Development and validation of an endoscopic index of the severity for Crohn’s disease: a prospective multicentre study. Groupe d’Etudes thérapeutiques des affections inflammatoires du tube digestif (GETAID). Gut. 1989;30(7):983–989. doi: 10.1136/gut.30.7.983.
   PubMed Web of Science ®Google Scholar
• Maaser C, Sturm A, Vavricka SR, et al. ECCO-ESGAR guideline for diagnostic assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis. 2019;13(2):144–164. doi: 10.1093/ecco-jcc/jjy113.
   PubMed Web of Science ®Google Scholar
• Novak KL, Nylund K, Maaser C, et al. Expert consensus on optimal acquisition and development of the international bowel ultrasound segmental activity score [IBUS-SAS]: a reliability and inter-rater variability study on intestinal ultrasonography in Crohn’s disease. J Crohns Colitis. 2021;15(4):609–616. doi: 10.1093/ecco-jcc/jjaa216.
   PubMed Web of Science ®Google Scholar
• Sævik F, Eriksen R, Eide GE, et al. Development and validation of a simple ultrasound activity score for Crohn’s disease. J Crohns Colitis. 2021;15(1):115–124. doi: 10.1093/ecco-jcc/jjaa112.
   PubMed Web of Science ®Google Scholar
• Allocca M, Craviotto V, Bonovas S, et al. Predictive value of bowel ultrasound in Crohn’s disease: a 12-month prospective study. Clin Gastroenterol Hepatol. 2022;20(4):e723–e740. doi: 10.1016/j.cgh.2021.04.029.
   PubMed Web of Science ®Google Scholar
• Ripollés T, Poza J, Suarez Ferrer C, et al. Evaluation of Crohn’s disease activity: development of an ultrasound score in a multicenter study. Inflamm Bowel Dis. 2021;27(1):145–154. doi: 10.1093/ibd/izaa134.
   PubMed Web of Science ®Google Scholar
• Dragoni G, Gottin M, Innocenti T, et al. Correlation of ultrasound scores with endoscopic activity in Crohn’s disease: a prospective exploratory study. J Crohns Colitis. 2023:jjad068. doi: 10.1093/ecco-jcc/jjad068. Epub ahead of print.
   Web of Science ®Google Scholar
• Wang L, Xu C, Zhang Y, et al. External validation and comparison of simple ultrasound activity score and international bowel ultrasound segmental activity score for Crohn’s disease. Scand J Gastroenterol. 2023;58(8):883–889.
   PubMedGoogle Scholar
• Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis. 2011;17(6):1314–1321. doi: 10.1002/ibd.21493.
   PubMed Web of Science ®Google Scholar
• Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn’s disease activity index. J Pediatr Gastroenterol Nutr. 1991;12(4):439–447. doi: 10.1097/00005176-199105000-00005.
   PubMed Web of Science ®Google Scholar
• Schober P, Boer C, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg. 2018;126(5):1763–1768. doi: 10.1213/ANE.0000000000002864.
   PubMed Web of Science ®Google Scholar
• Bryant RV, Friedman AB, Wright EK, et al. Gastrointestinal ultrasound in inflammatory bowel disease: an underused resource with potential paradigm-changing application. Gut. 2018;67(5):973–985. doi: 10.1136/gutjnl-2017-315655.
   PubMed Web of Science ®Google Scholar
• Moreno N, Ripollés T, Paredes JM, et al. Usefulness of abdominal ultrasonography in the analysis of endoscopic activity in patients with Crohn’s disease: changes following treatment with immunomodulators and/or anti-TNF antibodies. J Crohns Colitis. 2014;8(9):1079–1087. doi: 10.1016/j.crohns.2014.02.008.
   PubMed Web of Science ®Google Scholar
• Kellar A, Dolinger M, Novak KL, et al. Intestinal ultrasound for the pediatric gastroenterologist: a guide for inflammatory bowel disease monitoring in children: expert consensus on behalf of the international bowel ultrasound group (IBUS) pediatric committee. J Pediatr Gastroenterol Nutr. 2023;76(2):142–148. doi: 10.1097/MPG.0000000000003649.
   PubMed Web of Science ®Google Scholar
• Chavannes M, Hart L, Hayati Rezvan P, et al. Bedside intestinal ultrasound predicts disease severity and the disease distribution of pediatric patients with inflammatory bowel disease: a pilot cross-sectional study. Inflamm Bowel Dis. 2023:izad083. doi: 10.1093/ibd/izad083. Epub ahead of print.
   PubMed Web of Science ®Google Scholar
• de Voogd F, Bots S, Gecse K, et al. Intestinal ultrasound early on in treatment follow-up predicts endoscopic response to anti-TNFα treatment in Crohn’s disease. J Crohns Colitis. 2022;16(10):1598–1608. doi: 10.1093/ecco-jcc/jjac072.
   PubMed Web of Science ®Google Scholar
• Ripollés T, Paredes JM, Martínez-Pérez MJ, et al. Ultrasonographic changes at 12 weeks of anti-TNF drugs predict 1-year sonographic response and clinical outcome in Crohn’s disease: a multicenter study. Inflamm Bowel Dis. 2016;22(10):2465–2473. doi: 10.1097/MIB.0000000000000882.
   PubMed Web of Science ®Google Scholar
• Xu C, Li L, Zhang Y, et al. Diagnostic accuracy of different cross-sectional imaging techniques for disease location and activity in Crohn’s disease and external validation and comparison of MARIAs and IBUS-SAS. Abdom Radiol (NY). 2023;48(3):821–832. doi: 10.1007/s00261-022-03751-7.
   PubMed Web of Science ®Google Scholar
• Freitas M, de Castro FD, Macedo Silva V, et al. Ultrasonographic scores for ileal Crohn’s disease assessment: better, worse or the same as contrast-enhanced ultrasound? BMC Gastroenterol. 2022;22(1):252. doi: 10.1186/s12876-022-02326-6.
   PubMed Web of Science ®Google Scholar
• Civitelli F, Nuti F, Oliva S, et al. Looking beyond mucosal healing: effect of biologic therapy on transmural healing in pediatric Crohn’s disease. Inflamm Bowel Dis. 2016;22(10):2418–2424. doi: 10.1097/MIB.0000000000000897.
   PubMed Web of Science ®Google Scholar
• Calabrese E, Rispo A, Zorzi F, et al. Ultrasonography tight control and monitoring in Crohn’s disease during different biological therapies: a multicenter study. Clin Gastroenterol Hepatol. 2022;20(4):e711–e722.
   PubMed Web of Science ®Google Scholar
• Kucharzik T, Wittig BM, Helwig U, et al. Use of intestinal ultrasound to monitor Crohn’s disease activity. Clin Gastroenterol Hepatol. 2017;15(4):535–542.e2. e532. doi: 10.1016/j.cgh.2016.10.040.
   PubMed Web of Science ®Google Scholar
• Dillman JR, Dehkordy SF, Smith EA, et al. Defining the ultrasound longitudinal natural history of newly diagnosed pediatric small bowel Crohn disease treated with infliximab and infliximab-azathioprine combination therapy. Pediatr Radiol. 2017;47(8):924–934. doi: 10.1007/s00247-017-3848-3.
   PubMed Web of Science ®Google Scholar
• Zorzi F, Ghosh S, Chiaramonte C, et al. Response assessed by ultrasonography as target of biological treatment for Crohn’s disease. Clin Gastroenterol Hepatol. 2020;18(9):2030–2037.
   PubMed Web of Science ®Google Scholar
• Allocca M, Craviotto V, Dell’Avalle C, et al. Bowel ultrasound score is accurate in assessing response to therapy in patients with Crohn’s disease. Aliment Pharmacol Ther. 2022;55(4):446–454.
   PubMed Web of Science ®Google Scholar
• van Wassenaer EA, Benninga MA, van Limbergen JL, et al. Intestinal ultrasound in pediatric inflammatory bowel disease: promising, but work in progress. Inflamm Bowel Dis. 2022;28(5):783–787.
   PubMed Web of Science ®Google Scholar
• Dolinger MT, Choi JJ, Phan BL, et al. Use of small bowel ultrasound to predict response to infliximab induction in pediatric Crohn’s disease. J Clin Gastroenterol. 2021;55(5):429–432.
   PubMed Web of Science ®Google Scholar